Bioavailability boost: Capsugel to up micronization offering at US site

By Gareth Macdonald

- Last updated on GMT

iStock/Coprid
iStock/Coprid

Related tags Kohlberg kravis roberts Henry kravis

Capsugel plans to up micronisation capacity at Quakertown, Pennsylvania facility to provide API processing services for clinical candidates and commercial drugs.

The New Jersey, US firm gained the Quakertown plant in January when it completed the acquisition of Xcelience and Powdersize.

At present, the facility provides pharmaceutical industry customers with a range of particle size reduction services. It houses a pilot-scale micronisation suite.

Capsugel said the expansion – financial terms of which were not provided – will further expand its bioavailability enhancement offering when completed and operational in January.

The former-Pfizer unit’s focus for bioavailability has rapidly increased since it launched its dosage for business in in February 2013​.

Since then Capsugel has added capabilities from the acquisition of Encap​ and, in October 2013​, drug delivery firm Bend Research.

In May, it added micro-dose capabilities at its facility in Ploërmel, France.

At the time it said it had replicated micro-dosing operations at Xcelience​'s facility in Tampa Florida at the French site in order to be closer to European customers.

Takeover or IPO?

In April Reuters​ reported last week that Capsugel is "preparing to explore a sale or an initial public offering (IPO)​" suggesting that Danaher, 3M, Becton-Dickinson, Thermo Fisher Scientific, Bayer and Catalent.

Capsugel's owner US private equity investor Kohlberg Kravis Roberts (KKR) - which acquired the firm from Pfizer in 2011 – did not commented on the report.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Webinars

Headlines